- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Latest Lilly job cuts target marketing employees
May 7, 2010
J.K. WallIndianapolis-based drugmaker Eli Lilly and Co. is on course to cut 5,500 jobs by the end of 2011 in a bid to eliminate $1
billion in annual expenses.
MoreLilly sues to block copy of Evista osteoporosis drug
May 5, 2010
Bloomberg NewsWatson Pharmaceuticals filed for FDA approval to sell a low-cost version of Eli Lilly and Co.'s osteoporosis medicine. Indianapolis-based
Lilly is seeking a court order that would block approval until three of its patents expire in 2017.
MoreDrug prices rise ahead of rebates
April 21, 2010
J.K. WallDrug prices rose faster last year than they have in a decade—just in time for big rebates the drug industry promised
as part of the health reform law.
MoreShareholders fail to remove Lilly's anti-takeover provision
April 19, 2010
J.K. WallThe proposal to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly’s board received
approval from shareholders holding 74 percent of Lilly’s shares.
MoreShares fall after Lilly earnings report
April 19, 2010
J.K. WallLilly shareholders are set to gather Monday in Indianapolis to hear an update on the company’s performance, including
how it will keep paying its generous dividend during the lean years after Zyprexa’s patent expiration.
MoreLilly to pay $400M to repurchase Cymbalta rights
April 19, 2010
Bloomberg NewsEli Lilly and Co. will repurchase rights to develop and market antidepressant Cymbalta outside the U.S. and Japan from European
partner Boehringer Ingelheim for an initial payment of $400 million.
MoreHealth reform dings Lilly's earnings
April 19, 2010
J.K. WallThe Indianapolis-based drugmaker also lowered its forecast for full-year profits because the new health care law grants bigger
rebates on prescription drugs to federal health insurance programs.
MoreCan Lilly afford to maintain its dividend?
April 17, 2010
J.K. WallAs shareholders gather April 19 for Eli Lilly and Co.'s annual meeting, more of them than ever will come with an unusual question:
Will Lilly be able to keep paying its dividend?
MoreLilly sets date for move from Faris campus downtown
April 12, 2010
Work force reductions, new business structure make leased office space unnecessary. Moves will begin in late June.
MoreLilly diabetes drug may have cancer risk, FDA says
April 9, 2010
IBJ Staff and Bloomberg NewsOnce-weekly form of Byetta is awaiting the FDA's OK. Analyst predict the new version of the drug, if approved, could rack
up sales of $2 billion annually.
MoreLouisiana gets $20M in Lilly drug settlement
April 7, 2010
Associated PressLouisiana was one of 13 states that filed individual suits in state courts over allegations that Lilly pushed Zyprexa for
uses that had not been approved by federal regulators.
MoreLilly wins court ban on generic copy of Gemzar
April 1, 2010
Bloomberg News, Associated PressEli Lilly and Co. won a U.S. court ruling Wednesday that bars Teva Pharmaceutical Industries Ltd. from selling a generic version
of the cancer drug Gemzar until November.
MoreLilly drug wins U.K. backing as cancer therapy
April 1, 2010
Bloomberg NewsEli Lilly and Co.'s Alimta has received the preliminary backing of a United Kingdom agency as a maintenance treatment for
patients with the most common form of lung cancer.
MoreLilly to let 115 workers go in new outsourcing deal
March 26, 2010
J.K. WallDeal with unit of Massachusetts-based Thermo Fisher Scientific would keep many of the employees working in same
location.
MoreLilly eyes more animal-health acquisitions
March 25, 2010
IBJ Staff and Bloomberg NewsEli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.'s plan to
combine their veterinary units.
MoreLilly sues Hospira over generic version of Gemzar
March 24, 2010
Bloomberg NewsIndianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.
MoreLilly Endowment's assets drop more than foundation peers
March 24, 2010
Andrea Muirragui DavisOnce the nation’s wealthiest foundation, Indianapolis-based Lilly Endowment now ranks ninth among its grant-making
peers. The endowment’s value fell 15 percent last year, to an estimated $4.8 billion.
MoreBill kicks off years of change for local health care players
March 22, 2010
J.K. WallSweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.
MoreLilly sues to block generic of Adcirca lung treatment
March 17, 2010
Bloomberg NewsNetherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
MoreLilly victim of theft from Connecticut warehouse
March 16, 2010
IBJ Staff and Associated PressPharmaceuticals stolen Sunday morning could be worth up to $75 million.
MoreLilly pays $50M-plus for rights to testosterone lotion
March 16, 2010
Bloomberg NewsIndianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing
assets are transferred, but the deal could be worth millions more.
MoreFDA says 'not yet' on Lilly's once-weekly Byetta
March 15, 2010
J.K. WallRegulators won't require more time-consuming tests of the drug, but want Eli Lilly and Co. and its partners to clarify labeling,
manufacturing
processes.
MoreEli Lilly to buy European rights to Pfizer animal products
March 8, 2010
Scott OlsonThe acquisition will benefit Elanco, Lilly's animal health division in Greenfield, which has become increasingly important
to Lilly as it braces for patent-protection losses.
MoreMarket surge doesn't lift Lilly Endowment
March 6, 2010
Kathleen McLaughlinLilly Endowment's resistance to diversify its holdings reached a new height last year, as it failed to sell a single share
of the underperforming Eli Lilly and Co. stock while the broader market surged.
MoreThree Indiana companies among world's most admired
March 5, 2010
Brightpoint, WellPoint and Cummins are recognized by Fortune magazine as being among the best in their industries.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!